Stock Events

Stock Events

Sihuan Pharmaceutical Group 

$3.46
6
+$0+0% Wednesday 15:45

Statistics

Day High
2.75
Day Low
2.75
52W High
2.75
52W Low
2.75
Volume
50
Avg. Volume
-
Mkt Cap
32.28B
P/E Ratio
-
Dividend Yield
3.21%
Dividend
0.11

Upcoming

29
SEP
Dividend Ex
Estimated
 
23
OCT
Dividend Payment
Estimated
 
29
MAR 27
Dividend Ex
Estimated
 
23
APR 27
Dividend Payment
Estimated
 
29
SEP 27
Dividend Ex
Estimated
 

Dividends

3.21%Dividend Yield
Oct 25
$0.06
Oct 24
$0.11
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31MarExpected
Q4 2020
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0
0
0
0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-11.39%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
521.62MRevenue
-59.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHPHY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline is a global healthcare company that competes in various pharmaceutical sectors, including areas where Sihuan Pharmaceutical operates.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a large pharmaceutical company with a broad range of products that compete in the same market segments as Sihuan Pharmaceutical.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that offers products in multiple areas, including those where Sihuan Pharmaceutical is active, making it a direct competitor.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is a leading pharmaceutical company with a diverse product portfolio that competes with Sihuan Pharmaceutical's offerings.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson is a healthcare giant that operates in various pharmaceutical niches, competing with Sihuan Pharmaceutical across several product lines.
Sanofi
SNY
Mkt Cap110.4B
Sanofi is a global pharmaceutical company with a wide range of products that compete with Sihuan Pharmaceutical, especially in the areas of cardiovascular and metabolic diseases.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie is a research-based biopharmaceutical company with a strong presence in areas like immunology and oncology, competing with Sihuan Pharmaceutical.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with products that compete in the same therapeutic areas as Sihuan Pharmaceutical.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with Sihuan Pharmaceutical.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with Sihuan Pharmaceutical in several key areas.

About

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Show more...
CEO
Dr. Fengsheng Che
Employees
2843
Country
Bermuda
ISIN
US82674Q1058

Listings

STU
DE
TEL1.STU
OTC Link
US
SHPHY
F
DE
TEL1.F
MU
DE
TEL1.MU

0 Comments

Share your thoughts

FAQ

What is Sihuan Pharmaceutical Group stock price today?▼
The current price of SHPHY is $3.46 USD — it has increased by +0% in the past 24 hours. Watch Sihuan Pharmaceutical Group stock price performance more closely on the chart.
What is Sihuan Pharmaceutical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sihuan Pharmaceutical Group stocks are traded under the ticker SHPHY.
What is Sihuan Pharmaceutical Group market cap?▼
Today Sihuan Pharmaceutical Group has the market capitalization of 32.28B
When is the next Sihuan Pharmaceutical Group earnings date?▼
Sihuan Pharmaceutical Group is going to release the next earnings report on September 01, 2026.
What is Sihuan Pharmaceutical Group revenue for the last year?▼
Sihuan Pharmaceutical Group revenue for the last year amounts to 521.62M USD.
What is Sihuan Pharmaceutical Group net income for the last year?▼
SHPHY net income for the last year is -59.4M USD.
Does Sihuan Pharmaceutical Group pay dividends?▼
Yes, SHPHY dividends are paid semi-annual. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 3.21%.
How many employees does Sihuan Pharmaceutical Group have?▼
As of May 06, 2026, the company has 2,843 employees.
In which sector is Sihuan Pharmaceutical Group located?▼
Sihuan Pharmaceutical Group operates in the Health & Wellness sector.
When did Sihuan Pharmaceutical Group complete a stock split?▼
The last stock split for Sihuan Pharmaceutical Group was on June 05, 2014 with a ratio of 2:1.
Where is Sihuan Pharmaceutical Group headquartered?▼
Sihuan Pharmaceutical Group is headquartered in Wan Chai, Bermuda.